Corvus Pharmaceuticals (CRVS) Operating Expenses (2015 - 2026)
Corvus Pharmaceuticals (CRVS) recorded Operating Expenses of $19.3 million in Q2 2026, up 88.1% from $10.26 million a year earlier and up 29.7% from the prior quarter.
Powered by 
Analysis
Corvus Pharmaceuticals (CRVS) Operating Expenses (2015 - 2026) Analysis & Trends
On a TTM basis, Corvus Pharmaceuticals' Operating Expenses came in at $55.01 million as of Jun 30, 2026, up 64.8% year-over-year; for FY2023, it was $23.41 million, down 28.1% from FY2022.
- Annual Operating Expenses has declined for six straight years, with a five-year compound annual growth rate of -13.8% (FY2018 to FY2023).
- Across earlier years, Operating Expenses came in at $32.57 million in FY2022 (-15.7%), $38.63 million in FY2021 (-11.7%), $43.76 million in FY2020 (-10.4%) and $48.85 million in FY2019 (-0.7%).
- The Q2 2026 figure is the highest quarterly Operating Expenses in data going back to Q1 2015.
- Peak year-over-year performance for Operating Expenses in the last five years was growth of 88.1% in Q2 2026, against a decline of 55.4% in Q3 2023 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 10.12 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 10.56 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -6.09 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -9.70 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 6.54 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 18.20 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 6.68 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.09 Bn |
| 10 | Corvus Pharmaceuticals | 998.52 Mn | 486.96 Mn | - | 19.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.30 Mn |
| Mar 31, 2026 | 14.88 Mn |
| Sep 30, 2025 | 10.57 Mn |
| Jun 30, 2025 | 10.26 Mn |
| Mar 31, 2025 | 9.92 Mn |
| Sep 30, 2024 | 7.26 Mn |
| Jun 30, 2024 | 5.94 Mn |
| Mar 31, 2024 | 6.25 Mn |
| Dec 31, 2023 | 5.65 Mn |
| Sep 30, 2023 | 5.56 Mn |
| Jun 30, 2023 | 5.62 Mn |
| Mar 31, 2023 | 6.57 Mn |
| Dec 31, 2022 | 5.67 Mn |
| Sep 30, 2022 | 12.47 Mn |
| Jun 30, 2022 | 7.01 Mn |
| Mar 31, 2022 | 7.41 Mn |
| Dec 31, 2021 | 6.81 Mn |
| Sep 30, 2021 | 9.05 Mn |
| Jun 30, 2021 | 11.29 Mn |
| Mar 31, 2021 | 11.48 Mn |
API Access
Corvus Pharmaceuticals Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-expenses&ticker=CRVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-expenses", "ticker": "CRVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-expenses&ticker=CRVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();